天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片
RD Systems Company Information
Company Name:
R&D Systems, Inc
Tel:
-
Email:
rdname@qq.com
Nationality:
CHINA
WebSite:
www.rndsystems.com
Product List:
35705
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
Product List
(±)-Octanoylcarnitine chloride
14919-35-8
[D-p-Cl-Phe6,Leu17]-VIP
102805-45-8
(1057408) [Unconjugated]
(-)-Xestospongin C
88903-69-9
(S)-(-)-Bay K 8644
98625-26-4
[Arg8]-Vasopressin
113-79-1
(R)-Citalopram oxalate
219861-53-7
(R)-Baclofen
69308-37-8
(±)-AMG 487
947536-03-0
(R)-(-)-Rolipram
85416-75-7
(+)-Anabasine hydrochloride
53912-89-3
(R)-(-)-Phenylephrine hydrochloride
61-76-7
(+)-Muscarine iodide
24570-49-8
(R)-MG 132
1211877-36-9
(-)-[3R,4S]-Chromanol 293B
163163-24-4
(Z)-4-Hydroxytamoxifen
68047-06-3
(-)-Cytisine
485-35-8
(S)-Crizotinib
1374356-45-2
(S)-(-)-Propranolol hydrochloride
4199-10-4
(S)-4-Carboxyphenylglycine
134052-73-6
(R)-Norketamine hydrochloride
83777-68-8
(±)-ADX 71743
1431641-29-0
(Z)-Pugnac
132489-69-1
(E)-Capsaicin
404-86-4
(±)-PPCC oxalate
1781628-91-8
(-)-Nicotine ditartrate
65-31-6
(R)-CR8
1786438-30-9
(±)-Clopidogrel hydrochloride
130209-90-4
(R)-(+)-Bay K 8644
98791-67-4
(±)-J 113397
217461-40-0
(R,R)-THC
138090-06-9
(R)-(+)-Propranolol hydrochloride
13071-11-9
(S)-3,4-DCPG
201730-11-2
(RS)-(Tetrazol-5-yl)glycine
138199-51-6
(+)-JQ1 bump, acid functionalized
2421153-77-5
[Leu31,Pro34]-Neuropeptide Y (human, rat)
132699-73-1
(+)-PD 128907 hydrochloride
300576-59-4
[Ala11,D-Leu15]-Orexin B
532932-99-3
(+)-Bicuculline
485-49-4
(±)-Epibatidine
148152-66-3
(RS)-(±)-Sulpiride
15676-16-1
(RS)-3,5-DHPG
146255-66-5
(S)-(-)-Sulpiride
23672-07-3
(-)-Quinpirole hydrochloride
85798-08-9
(d(CH2)51,Tyr(Me)2,Arg8)-Vasopressin
73168-24-8
(±)-NBI 74330
473722-68-8
(+)-U-50488 hydrochloride
114528-81-3
(RS)-CPP
100828-16-8
(2R,4R)-APDC
169209-63-6
(±)-trans-ACPD
67684-64-4
(-)-JQ1
1268524-71-5
[D-Ala2]-GIP (human)
444073-04-5
(S)-AMPA
83643-88-3
(±)-CPSI 1306
1309793-47-2
(S)-PFI 2 hydrochloride
1627607-88-8
(R)-(+)-Etomoxir sodium salt
828934-41-4
(R)-PFI 2 hydrochloride
1627607-87-7
(R)-(-)-Apomorphine hydrochloride
314-19-2
(RS)-Baclofen
1134-47-0
(+)-JQ1 maleimide
(S)-(-)-Blebbistatin
856925-71-8
(-)-U-50488 hydrochloride
114528-79-9
(R)-(+)-HA-966
123931-04-4
(S)-WAY 100135 dihydrochloride
149007-54-5
(R)-DRF053 dihydrochloride
1241675-76-2
[D-Lys3]-GHRP-6
136054-22-3
(RS)-AMPA
77521-29-0
(±)-Blebbistatin
674289-55-5
(RS)-AMPA hydrobromide
171259-81-7
(5Z)-7-Oxozeaenol
253863-19-3
(+)-Clopidogrel hydrogen sulfate
120202-66-6
(±)-U-50488 hydrochloride
67197-96-0
(R)-2-Hydroxyglutaric acid disodium salt
103404-90-6
(+)-MK 801 maleate
77086-22-7
(R)-ZINC 3573
2089389-15-9
(RS)-MCPG disodium salt
1303994-09-3
(D)-PPA 1
1620813-53-7
(-)-Bicuculline methobromide
66016-70-4
[D-Ala2]-Deltorphin II
122752-16-3
(±)-Eriodictyol
4049-38-1
(±)-5'-Chloro-5'-deoxy-ENBA
103626-26-2
(-)-MK 801 maleate
121917-57-5
(S)-(-)-Carbidopa
28860-95-9
(-)-Bicuculline methiodide
40709-69-1
(R)-CE3F4
1593478-56-8
(-)-Bicuculline methochloride
38641-83-7
(R)-CPP
126453-07-4
(RS)-MCPG
146669-29-6
(RS)-2-Hydroxyglutaric acid disodium salt
40951-21-1
(+)-JQ1
1268524-70-4
(S)-MCPG
150145-89-4
(±)-ML 209
1334526-14-5
(S)-Duloxetine hydrochloride
136434-34-9
(S)-(-)-5-Iodowillardiine
140187-25-3
(S)-SNAP 5114
157604-55-2
(S)-3,5-DHPG
162870-29-3
(R)-(-)-α-Methylhistamine dihydrobromide
868698-49-1
(+)-Igmesine hydrochloride
130152-35-1
(±)-Bay K 8644
71145-03-4
(S)-(+)-Dimethindene maleate
136152-65-3
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
Copyright 2007© ChemicalBook. All rights reserved.